Live feed
Filing
SC 13G/A
SC 13G/A0000728889-18-000285·OppenheimerFunds, Inc.
Schedule 13G ownership disclosure
RIGEL PHARMACEUTICALS INC
Security class unavailable · CUSIP: 766559603
Event date: 2017-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,010,160
- Percent of class
- 3.4200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000728889-18-000285
- Form type
- SC 13G/A
- Filer
- OppenheimerFunds, Inc.
- CIK
- CIK 728889
- Filed
- Feb 12, 2018
- Reporting period
- Dec 31, 2017
- Description
- Schedule 13G beneficial ownership